Browsing Topic

ASX ATH

1 post

Alterity wins FDA fast-track for ATH434 – but with 9B shares on issue, impact diluted

Alterity Therapeutics (ASX:ATH), dual-listed on both the ASX and the NASDAQ, is the latest Aussie biotech…
  • 2 mins
  • 05 May 2025 10:53 (AEDT)